Hostname: page-component-7bb8b95d7b-495rp Total loading time: 0 Render date: 2024-09-28T05:19:54.988Z Has data issue: false hasContentIssue false

P03-319 - The Truth About Polypharmacy in Elderly Inpatient Population

Published online by Cambridge University Press:  17 April 2020

A. Kumar
Affiliation:
Derbyshire Mental Health Services NHS Trust, Radbourne Unit/ NHS, Derby, UK
A. Kapila
Affiliation:
Year 7 Student, Nottingham High School, Nottingham, UK

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

There is increasing concern about the use of multiple medications in psychiatric patients.Older adults make up 15% of the population yet they account for 30% of the prescribed medications. There is increased risk of falls, confusion and consequent functional decline as a result of potential interactions and adverse drug events.

Aims/Objectives

To document the extent of polypharmacy and potential drug interactions in elderly inpatient population at the point of discharge.

Methods

25 consecutive discharge summaries from an elderly mixed (organic and functional) inpatient unit were evaluated.

Results

out of 25 (15 female and 10 male) patients with age range of 59-97 years, an average of 6.5 drugs (Range:2-17; Median:6) were prescribed. An average of 3.1 pair of interactions (Range:0-15; Median:3) were noted. Potentially hazardous interactions (Average 0.68; Range:0-4) was a worrying trend in this patient group.

Conclusions

Polypharmacy is commonplace in elderly patients and is worrisome. Different strategies like in-house pharmacist may offer some safeguards though further research is needed.

Type
Psychopharmacological treatment and biological therapies
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.